ALDOSTERONE is the most recently discovered natural product of the adrenal cortex, and it seems it represents a very significant part of the activity of the old so-called amorphous fraction of adrenal extract obtained as a residue by Kendall and others after separating out the crystalline materials. The isolation, which sprang from the foundations laid by Drs. Simpson and Tait at the Middlesex Hospital, was greatly facilitated by the sensitivity of the rat to this substance (or electrocortin as it was originally called) in respect of sodium reabsorption by the kidney tubule. It is almost by definition therefore that aldosterone is a powerful sodium-retaining substance. It thus became important to determine in what other way it showed biological activity. Since a wide range of methods in the general field of adrenal physiology were already to hand, advances in this direction have been extremely rapid and comprehensive in spite of severe limitation set by the difficulties and cost of the isolation procedures for aldosterone. For instance about 5 mg. comes from 100 kilograms of beef adrenals (Wettstein, 1954) . The work to be described in the present paper has been carried out with the use of 12-5 mg. of aldosterone kindly supplied by the Ciba Co. of Basel, through
the courtesy of Dr. F. Gross.
At the time of commencement of this work observations in man had been very restricted.
Mach et al. (1954) had reported on the administration of aldosterone to 2 patients with Addison's disease for a total time of eleven days and made a careful study of the metabolic effects. Simpson and Tait (1955) had described the effect of aldosterone on the salivary Na/K ratio in normal persons and a patient with Addison's disease. The greater part of our general knowledge has, of course, come from animal experiments, since for these much smaller amounts of hormone are required. Maintenance of the adrenalectomized dog in a satisfactory state demonstrated the life-saving properties of this substance under these conditions (Gross and Gysel, 1954) . These authors and Spiers et al. (1954) also observed that it was one-half to one-third as active in depressing the eosinophil count of adrenalectomized mice. At about the same time Schuler et al. (1954) in Switzerland found that it was about one-third as potent as cortisone in causing the deposition of glycogen in the mouse liver, requiring 100 Htg. per mouse to cause a 200 % rise in glycogen content.
The present paper summarizes the effects of aldosterone administration to 8 patients.
Our investigations began with the confirmation of the therapeutic effect in Addison's disease. In our first patient (E. W.), after complete withdrawal of therapy, administration of aldosterone in doses of 200 pg. for three days and 400 pg. on the last two days checked and even reversed the metabolic changes and weight loss thus ensuing. Clinically the patient was in excellent shape during this short period of replacement of conventional treatment by aldosterone, which during this time had little effect on blood pressure and no noticeable effect on pigmentation which Mach et al. (1954) and Soffer (1955) had found to be improved.
There was in this patient a considerable diuresis and natriuresis on withdrawal of therapy possibly due to some previous overtreatment (Prunty et al., 1954) . This may to some extent have favoured the very considerable retention of sodium and chloride promoted by aldosterone. It must be noted that sodium was retained in excess of chloride, suggesting the possibility of intracellular transfer of some 130 mnEq. of sodium. Potassium balance was not, in this individual, strikingly affected. It was also noted that there was a significantly more positive water balance, accompanied by a check in the fall and even a slight rise in weight. Further observations were made on a girl with adrenal hyperplasia leading to pseudohermaphroditism (M. W.) (loc. cit.). These exactly confirmed this picture in all respects, but there was, in addition, a significant change in potassium balance involving a considerable rebound retention. The dosage of aldosterone given to this individual was somewhat greater, being 500 pug. the first day and 1050 pg. the next two days. The change in the ratio of K/Na is perhaps the most sensitive index of the effect of aldosterone on urine electrolyte excretion. In this patient in a twenty-four-hour urine sample it reached a peak of 1-8. The water balance appeared to become more positive. It was pointed out at the time that there was a great falling off in sodium retention and the K/Na ratio when 750 pg. of aldosterone were given intravenously over a twenty-four-hour period immediately at the conclusion of the intramuscular series of doses. The administration of aldosterone to these patients led to changes in the serum electrolytes which were difficult to interpret in E. W., but it is noteworthy that there was a persistent fall in serum chloride level during the period of aldosterone administration. In the second patient there was expected rise in serum sodium accompanied by a fall in hlmatocrit level. Comparison of the effects of aldosterone with those of cortisone in doses of 75 to 100 mg. showed that with the latter retention of sodium and chloride over an eight-day period was very small in comparison with the changes seen 21 with the large doses of aldosterone, although the effects on potassium excretion were greater. The nitrogen balance did not show that this was due to increased protein breakdown induced by cortisone, but this effect may have been counterbalanced by the endogenous over-production of androgen from the hyperplastic adrenal cortex. This recalls the poor ability of cortisone to cause sodium retention previously observed in Addison's disease, (Prunty et al., 1954) . Aldosterone did not increase nitrogen excretion in either of these patients.
More detailed comparison of the effects of aldosterone administered by different routes has been made (Prunty et al., 1955) . The technique adopted was to observe the effects of single doses on patients on a balanced regime. Each observation day alternated with a control day. Treatment was withdrawn from the Addison's patients. The dose given was usually 250 ,ug. Intravenous administration was at a uniform rate in 500 ml. 2 5 Y. glucose over a five-hour period. The data on the duration of action by the intramuscular route were confirmed. In a second Addisonian (P. M.) and a gastric ulcer (C. T.) approximately 30 mEq. of sodium were retained in twenty-four hours. The peak K/Na ratio was approximately 4, occurring in the third to fifth hour period. Intravenous infusion was somewhat less effective and oral dosing least so, in one experiment having no effect on the K/Na ratio. Note very large retention after stopping ACTH.
J.A. T21
In a third Addisonian (V. C.) 225 ,ug. of intravenous aldosterone produced good sodium retention, comparable with the intramuscular responses previously observed but somewhat less than the response from 5 mg. of DCA. Potassium loss was also considerable under these conditions with aldosterone, rising from control levels of 40 ,tEq. per minute to 100 ,tEq. per minute at the end of the infusion. The DCA had less effect on potassium excretion.
Observations on water excretion have shown that the abnormal diurnal rhythm of Addison's disease is not corrected nor is the capacity for normal diuresis restored (Prunty et al., 1954) . There was slight but definite evidence of water retention in patients E. W. and M. W. In patient P. M. the normal urine flow was halved. This is of importance since Gross and Gysel (1954) suggested that unlike DCA aldosterone had little effect on water retention and it might be hoped that water overloading could be avoided. Our findings are consistent with those of Ward et al. (1954) who found significant rapid weight gain in patients with rheumatoid arthritis and of Thorn (1955) in an Addisonian receiving 1 mg. daily for seven days.
We have observed no effect of aldosterone at any time on eosinophil counts, even after 1 mg. doses. Careful review of the data published on sugar metabolism (Kekwick and Pawan, 1954; Mach et al., 1954; Prunty et al., 1954) shows the changes observed were inconstant. To investigate the position further the effect of aldosterone on the fasting blood sugar and insulin tolerance in a patient with Addison's disease (G. D.) and a patient adrenalectomized for prostatic carcinoma (H. T.) was investigated. No increase in the fasting blood sugar levels was observed and no decrease of the sensitivity to insulin (Prunty et aL, 1955) . This leads us to revise our previous opinion about the effects of aldosterone doses up to 1 mg. on carbohydrate metabolism in man, and makes us think there is no significant effect. This is consistent with the failure to observe depression of ketosteroid excretion in the patient with adrenal hyperplasia (M. W.) with doses of this magnitude. -Continued sodium retention in the same patient, relieved by Neptal and cortisone. Note the period from day 0-15 is the same as that in Fig. 1 . On day 110 the "balance" was discontinued and the figures represent urine sodium excretion.
[ Figs. 1 and 2 are reproduced from Proceedings of the Tenth International Congress of Dermatology, London, 1952 (Prunty, 1953) 
by kind permission.]
We should like to turn now to a more speculative note and discuss some findings made several years ago in a patient with dermatomyositis (Prunty, 1953) . This patient was treated with ACTH in doses up to 100 units daily for fourteen days in an acute phase of the disease (Fig. 1) . The expected change in sodium balance occurred, namely considerable sodium retention which diminished on reduction of the dose of ACTH. On the day after withdrawal of ACTH sodium excretion suddenly decreased to 1 mEq. per day or less and despite an intake of 30 or more milli-equivalents per day remained at this low level until cortisone was given on day 60 and returned after its withdrawal on day 100 (Fig. 2) . The pathological retention was relieved by Neptal, cortisone and ACTH. Three days after Neptal injection, despite elevation of K intake, the serum potassium level was only 2-35 mEq./l. Potassium balance data during this phase showed the patient to be in strongly negative balance. These findings recall those of Conn (1955) in a patient with an adrenal tumour and excessive aldosterone excretion in the urine. They raise the possibility that the ACTH administration might have "triggered off", perhaps together with the low Na intake, the secretion of aldosterone, the action of which was opposed by cortisone. The precise relationship of aldosterone secretion to ACTH stimulation is still obscure. The failure of diminution of steroid excretion in the girl, M. W., given aldosterone is against an ACTH dependence, but possibly the dose of aldosterone may have been too little. The experiments of Cope and Garcia-Llaurado (1954) and of Axelrad et al. (1954) seem to indicate that aldosterone production is ACTH independent. However, the recent report of Singer and Stack-Dunne (1955) working with rats, shows that, in this animal at least, ACTH plays a part in stimulating aldosterone secretion, although the physiological mechanism seems more complicated. It still seems to the authors that in man the very strong sodium-retaining effects of ACTH require the participation of a "mineralocorticoid" in the response.
Summary.-Aldosterone may be used as replacement therapy in Addison's disease in doses up to 200 ,ug. daily. The duration of action is short and most pronounced by the intramuscular route. It causes intense Na retention and some potassium excretion in these doses with a large change in urine K/Na. It seems to cause intracellular transfer of Na and shift of water from cells to interstitial fluid as does DCA. It is approximately 25 times as active as DCA. Water retention is produced but not normal water diuresis in an adrenaldeficient patient. It seems to lack the carbohydrate corticoid effects of cortisone in doses up to 1 mg.
